Royal Bank of Canada’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Buy |
10,043
+4,253
| +73% | +$155K | ﹤0.01% | 4377 |
|
|
2025
Q1 | $209K | Sell |
5,790
-63,952
| -92% | -$2.31M | ﹤0.01% | 4327 |
|
|
2024
Q4 | $2.93M | Buy |
69,742
+3,612
| +5% | +$152K | ﹤0.01% | 2405 |
|
|
2024
Q3 | $3.67M | Buy |
66,130
+61,452
| +1,314% | +$3.41M | ﹤0.01% | 2232 |
|
|
2024
Q2 | $191K | Sell |
4,678
-2,120
| -31% | -$86.6K | ﹤0.01% | 4428 |
|
|
2024
Q1 | $317K | Sell |
6,798
-26,449
| -80% | -$1.23M | ﹤0.01% | 3892 |
|
|
2023
Q4 | $1.59M | Sell |
33,247
-2,502
| -7% | -$120K | ﹤0.01% | 2809 |
|
|
2023
Q3 | $1.27M | Sell |
35,749
-20,986
| -37% | -$747K | ﹤0.01% | 2819 |
|
|
2023
Q2 | $2.62M | Sell |
56,735
-43
| -0.1% | -$1.98K | ﹤0.01% | 2309 |
|
|
2023
Q1 | $2.28M | Buy |
56,778
+52,528
| +1,236% | +$2.11M | ﹤0.01% | 2408 |
|
|
2022
Q4 | $197K | Buy |
4,250
+490
| +13% | +$22.7K | ﹤0.01% | 4445 |
|
|
2022
Q3 | $155K | Sell |
3,760
-3,092
| -45% | -$127K | ﹤0.01% | 4496 |
|
|
2022
Q2 | $410K | Sell |
6,852
-399
| -6% | -$23.9K | ﹤0.01% | 3824 |
|
|
2022
Q1 | $526K | Sell |
7,251
-1,476
| -17% | -$107K | ﹤0.01% | 3780 |
|
|
2021
Q4 | $734K | Buy |
8,727
+739
| +9% | +$62.2K | ﹤0.01% | 3647 |
|
|
2021
Q3 | $719K | Sell |
7,988
-24,018
| -75% | -$2.16M | ﹤0.01% | 3549 |
|
|
2021
Q2 | $3.05M | Buy |
32,006
+25,627
| +402% | +$2.44M | ﹤0.01% | 2374 |
|
|
2021
Q1 | $727K | Buy |
6,379
+1,418
| +29% | +$162K | ﹤0.01% | 3439 |
|
|
2020
Q4 | $686K | Buy |
4,961
+2,596
| +110% | +$359K | ﹤0.01% | 3376 |
|
|
2020
Q3 | $194K | Buy |
2,365
+1,156
| +96% | +$94.8K | ﹤0.01% | 4111 |
|
|
2020
Q2 | $95K | Buy |
1,209
+1,036
| +599% | +$81.4K | ﹤0.01% | 4420 |
|
|
2020
Q1 | $8K | Sell |
173
-2,358
| -93% | -$109K | ﹤0.01% | 5403 |
|
|
2019
Q4 | $107K | Buy |
2,531
+992
| +64% | +$41.9K | ﹤0.01% | 4468 |
|
|
2019
Q3 | $65K | Buy |
1,539
+1,334
| +651% | +$56.3K | ﹤0.01% | 4429 |
|
|
2019
Q2 | $12K | Sell |
205
-1,018
| -83% | -$59.6K | ﹤0.01% | 5135 |
|
|
2019
Q1 | $85K | Buy |
1,223
+268
| +28% | +$18.6K | ﹤0.01% | 4258 |
|
|
2018
Q4 | $42K | Sell |
955
-1,300
| -58% | -$57.2K | ﹤0.01% | 4520 |
|
|
2018
Q3 | $172K | Buy |
2,255
+230
| +11% | +$17.5K | ﹤0.01% | 3972 |
|
|
2018
Q2 | $155K | Buy |
2,025
+1,702
| +527% | +$130K | ﹤0.01% | 3991 |
|
|
2018
Q1 | $16K | Sell |
323
-271,522
| -100% | -$13.5M | ﹤0.01% | 4930 |
|
|
2017
Q4 | $12.6M | Buy |
271,845
+41,758
| +18% | +$1.94M | 0.01% | 1197 |
|
|
2017
Q3 | $12.3M | Buy |
230,087
+5,826
| +3% | +$310K | 0.01% | 1158 |
|
|
2017
Q2 | $13.9M | Buy |
224,261
+202,556
| +933% | +$12.6M | 0.01% | 1071 |
|
|
2017
Q1 | $1.47M | Sell |
21,705
-133,099
| -86% | -$9.02M | ﹤0.01% | 2300 |
|
|
2016
Q4 | $10.9M | Sell |
154,804
-6,934
| -4% | -$488K | 0.01% | 1191 |
|
|
2016
Q3 | $11.5M | Buy |
161,738
+28,314
| +21% | +$2.01M | 0.01% | 1150 |
|
|
2016
Q2 | $6.53M | Buy |
133,424
+17,941
| +16% | +$878K | ﹤0.01% | 1428 |
|
|
2016
Q1 | $7.31M | Buy |
115,483
+115,451
| +360,784% | +$7.31M | ﹤0.01% | 1333 |
|
|
2015
Q4 | $4K | Sell |
32
-1,766
| -98% | -$221K | ﹤0.01% | 5452 |
|
|
2015
Q3 | $173K | Sell |
1,798
-2,402
| -57% | -$231K | ﹤0.01% | 3869 |
|
|
2015
Q2 | $430K | Sell |
4,200
-7,100
| -63% | -$727K | ﹤0.01% | 3293 |
|
|
2015
Q1 | $702K | Buy |
+11,300
| New | +$702K | ﹤0.01% | 2766 |
|